You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Litigation Details for Alcon Inc. v. Padagis Israel Pharmaceuticals Ltd. (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

Alcon Inc. v. Padagis Israel Pharmaceuticals Ltd. (D. Del. 2022)

Docket	⤷ Try a Trial	Date Filed	2022-10-27
Court	District Court, D. Delaware	Date Terminated
Cause	35:1 Patent Infringement	Assigned To	William C. Bryson
Jury Demand	None	Referred To
Parties	PADAGIS ISRAEL PHARMACEUTICALS LTD.
Patents	9,044,484; 9,421,265
Attorneys	Andrea L. Cheek
Firms	Phillips, McLaughlin & Hall, P.A.
Link to Docket	External link to docket

Small Molecule Drugs cited in Alcon Inc. v. Padagis Israel Pharmaceuticals Ltd.

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Details for Alcon Inc. v. Padagis Israel Pharmaceuticals Ltd. (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2022-10-27	1	Complaint	expiration of U.S. Patent Nos. 9,044,484 and 9,421,265 (collectively, the “Asserted Patents”). …BACKGROUND 22. U.S. Patent No. 9,044,484 (“the ’484 Patent”), entitled “Aqueous Pharmaceutical… COUNT I: INFRINGEMENT OF U.S. PATENT NO. 9,044,484 35. The Alcon Parties incorporate…claim 1 of the ’484 Patent and at least claim 1 of the ’265 Patent. The Asserted Patents have been listed… COMPLAINT FOR PATENT INFRINGEMENT 1. This is an action for patent infringement by Alcon	External link to document
2024-03-01	119	Notice of Service	Ph.D. Regarding the Invalidity of U.S. Patent Nos. 9,044,484 and 9,421,265 filed by Padagis Israel Pharmaceuticals… 27 October 2022 1:22-cv-01422 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-10-27	3	ANDA Form	Expiration of U.S. Patent No. 9,044,484: October 30, 2030. Expiration of U.S. Patent No. 9,421,265: June… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 27 October 2022 1:22-cv-01422 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-10-27	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,044,484 B2 ; US 9,421,265… 27 October 2022 1:22-cv-01422 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-11-02	7	ANDA Form	Expiration of Patent: U.S. Patent No. 9,044,484: October 30, 2030 Date of Expiration of U.S. Patent No. 9,421,265… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application… 27 October 2022 1:22-cv-01422 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.